Archivo de categoría: Mastopatología

Low-risk DCIS. What is it? Observe or excise?

Pinder, S.E., Thompson, A.M. & Wesserling, J. Low-risk DCIS. What is it? Observe or excise?. Virchows Arch 480, 21–32 (2022). https://doi.org/10.1007/s00428-021-03173-8 Abstract The issue of overdiagnosis and overtreatment of lesions detected by breast screening mammography has been debated in both international media and the scientific literature. A proportion of cancers detected by breast screening would never haveSigueSigue leyendo «Low-risk DCIS. What is it? Observe or excise?»

Breast carcinomas of low malignant potential.

Schnitt, S.J., Fend, F. & Decker, T. Breast carcinomas of low malignant potential. Virchows Arch 480, 5–19 (2022). https://doi.org/10.1007/s00428-021-03163-w Abstract Some breast carcinomas have a very low likelihood of metastasis to regional lymph nodes and distant sites and may be considered carcinomas of low malignant potential. In this article, we review the clinical, pathologic, immunophenotypic, and molecularSigueSigue leyendo «Breast carcinomas of low malignant potential.»

Multidisciplinary Masterclass on Breast Cancer.

– Programa – 9 de julio de 2021. 14:45. Bienvenida. Dr Gérard Friedlander – University of Paris Foundation, France. 15:00. Imaging work-up of breast masses. Dr. Marc Abehsera – American Hospital of Paris, Neuilly sur Seine, France.15:30. 2019 WHO updates on breast tumor classification. Dr Paula Ginter – Weill Cornell Medicine, New York, USA.16:00. TrickySigueSigue leyendo «Multidisciplinary Masterclass on Breast Cancer.»

Curso on-line: Cáncer de Mama: Manejo y controversias 2021.

Curso Organizado por la Umberto Veronesi Academy (UVAC)y la University of California – San Diego. Director del Curso: Prof. Paolo Veronesi.Director General UVAC: Gabriel Farante.Directores Regionales UVAC: Antonio Frasson – Alberto Rancati. Contenido y contribución científica: Istituto Europeo di Oncologia (Milán, Italia) – Memorial Sloan Kettering Cancer Center (New York, NY, USA) – MD AndersonSigueSigue leyendo «Curso on-line: Cáncer de Mama: Manejo y controversias 2021.»

Jornadas Provinciales – «Reunión Conjunta IPC – SOGBA»

PRESIDENTES: Dra. LILIANA CARRERA – Dr. HERNÁN FARINACoordinadoras: Dra. Silvia Ferroni – Dra. Silvia Massaccesi 6 de noviembre de 2021 PLATAFORMA WEBEX – Escuela de Gobierno en Salud “Floreal Ferrara” 9-9.15 HS – ACTO DE APERTURAPRESIDENTE SOGBA: Dra. Liliana CarreraDIRECTOR IPC: Dr. Hernán Farina 9.15 – 10.15 HS – PRIMERA SESIÓNDra. Laura Escalante Albertali – Dra. SilviaSigueSigue leyendo «Jornadas Provinciales – «Reunión Conjunta IPC – SOGBA»»

SOGBA 2017.

La Sociedad de Obstetricia y Ginecología de la Provincia de Bs. As. (SOGBA) anuncia la realización de su XVIII Congreso Internacional. La sede para este año es el Intersur Hotel 13 de julio ubicado en

New horizon in breast cancer therapy: highlights from the European Society for Medical Oncology. Open Access.

Abstract: This podcast presents an overview of new therapies on the horizon for breast cancer in terms of data presented at the European Society for Medical Oncology Congress, American Society of Clinical Oncology and the San Antonio Breast Cancer Symposium. In the adjuvant setting, results from the Microarray In Node negative Disease may Avoid ChemoTherapy (MINDACT) trial,SigueSigue leyendo «New horizon in breast cancer therapy: highlights from the European Society for Medical Oncology. Open Access.»

Influence of decalcification procedures on immunohistochemistry and molecular pathology in breast cancer.

Willemijne A M E Schrijver, Petra van der Groep, Laurien DC Hoefnagel, Natalie D ter Hoeve, Ton Peeters, Cathy B Moelans and Paul J van Diest.   Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands. Abstract: Distant breast cancer metastases are nowadays routinely biopsied to reassess receptor status and to isolateSigueSigue leyendo «Influence of decalcification procedures on immunohistochemistry and molecular pathology in breast cancer.»

Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer.

Bradley B Bryan, Stuart J Schnitt and Laura C Collins. Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA. Abstract: Basal-like carcinomas have recently been identified in gene expression profiling studies as a subtype of invasive breast cancer. These lesions are estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative (triple negative), andSigueSigue leyendo «Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer.»

Differentiating Lymphovascular Invasion from Retraction Artifact on Histological Specimen of Breast Carcinoma and Their Implications on Prognosis.

Nicholas George Zaorsky, Ninad Patil,1 Gary Mitchel Freedman,2 and Madalina Tuluc3. Department of Pathology, Fox Chase Cancer Center, Philadelphia, USA. Department of Radiation Oncology, University of Pennsylvania, Philadelphia, USA. Department of Pathology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, USA. Abstract: On a pathological specimen of breast cancer cells, retraction artifact during histological processing mimicsSigueSigue leyendo «Differentiating Lymphovascular Invasion from Retraction Artifact on Histological Specimen of Breast Carcinoma and Their Implications on Prognosis.»

Effect of Occult Metastases on Survival in Node-Negative Breast Cancer.

Original Article. Donald L. Weaver, M.D., Takamaru Ashikaga, Ph.D., David N. Krag, M.D., Joan M. Skelly, M.S., Stewart J. Anderson, Ph.D., Seth P. Harlow, M.D., Thomas B. Julian, M.D., Eleftherios P. Mamounas, M.D., and Norman Wolmark, M.D. Abstract. Background: Retrospective and observational analyses suggest that occult lymph-node metastases are an important prognostic factor for diseaseSigueSigue leyendo «Effect of Occult Metastases on Survival in Node-Negative Breast Cancer.»